ABVC BioPharma, Inc. (ABVC) Stock Statistics & Valuation Metrics

ABVC BioPharma, Inc. has a market cap or net worth of $13.62M. The enterprise value is $10.00M.

ABVC BioPharma, Inc. has 12.98M shares outstanding. The number of shares has decreased by -2.65% in one year.

ABVC BioPharma, Inc.’s return on equity (ROE) is -1.25 and return on invested capital (ROIC) is -80.67%.

The current PE Ratio of ABVC BioPharma, Inc. is -0.48. ABVC BioPharma, Inc.’s PEG ratio is <0.01.

In the last 12 months, ABVC BioPharma, Inc. had revenue of $509.79K and earned -$8.24M in profits. Earnings per share was -$0.90.

In the last 12 months, operating cash flow was -$1.91M and capital expenditures $21.20K, giving a free cash flow of -$1.89M billion.

ABVC BioPharma, Inc. pays an annual dividend of , resulting in a dividend yield of

ABVC BioPharma, Inc. upcoming earnings date is Nov 17, 2025, After Close.

ABVC BioPharma, Inc. as a current ratio of 0.28, with Debt / Equity ratio of 0.27

In the past 12 months, ABVC BioPharma, Inc. has paid -$3.87M in taxes.

ABVC BioPharma, Inc. EV to EBITDA ratio is -0.89, with an EV/FCF ratio of -1.70.

ABVC BioPharma, Inc. has $208.15K in cash and marketable securities with $2.33M in debt, giving a net cash position of $2.12M billion.

Gross margin is -98.15%, with operating margin of -5390.35%, and net profit margin of -6898.68%.

The average price target for ABVC BioPharma, Inc. is , which is 11.43% higher than the current price. The consensus rating is